New opportunities for field research on the pathogenesis and treatment of Lassa fever

被引:131
作者
Khan, Sheik Humarr [1 ,2 ]
Goba, Augustine [1 ,2 ]
Chu, May [3 ]
Roth, Cathy [3 ]
Healing, Tim [3 ]
Marx, Arthur [3 ]
Fair, Joseph [1 ,4 ]
Guttieri, Mary C. [4 ]
Ferro, Philip [4 ]
Imes, Tiffany [1 ]
Monagin, Corina [1 ]
Garry, Robert F. [1 ]
Bausch, Daniel G. [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA
[2] Kenema Govt Hosp, Minist Hlth & Sanitat, Kenema, Sierra Leone
[3] WHO, CH-1211 Geneva, Switzerland
[4] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA
关键词
Lassa virus; Lassa fever; Arenavirus; viral hemorrhagic fever; West Africa; antiviral therapy; ribavirin; pathogenesis;
D O I
10.1016/j.antiviral.2007.11.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Unlike many viral hemorrhagic fevers (VHFs), Lassa fever (LF) is not a rare disease that emerges only as sporadic cases or in outbreak form. Although surveillance is inadequate to determine the true incidence, up to 300,000 infections and 5000 deaths from LF are estimated to occur yearly. The highest incidence is in the "Mano River Union (MRU) countries" of Sierra Leone, Liberia, and Guinea. Although civil unrest in this region over the past two decades has impeded capacity building and research, new-found peace in recent years presents new opportunities. In 2004, the Mano River Union Lassa Fever Network (MRU LFN) was established to assist NIRU countries in the development of national and regional surveillance, diagnosis, treatment, control, and prevention of LF. Here, we review the present literature on treatment and pathogenesis of LF and outline priorities for future research in the field made possible by the improved research capacity of the MRU LFN. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 115
页数:13
相关论文
共 114 条
[1]   TUMOR-NECROSIS-FACTOR AND THE PATHOGENESIS OF PICHINDE VIRUS-INFECTION IN GUINEA-PIGS [J].
ARONSON, JF ;
HERZOG, NK ;
JERRELLS, TR .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (03) :262-269
[2]   Inhibition of different lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus [J].
Asper, M ;
Sternsdorf, T ;
Hass, M ;
Drosten, C ;
Rhode, A ;
Schmitz, H ;
Günther, S .
JOURNAL OF VIROLOGY, 2004, 78 (06) :3162-3169
[3]   Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages [J].
Baize, S ;
Pannetier, D ;
Faure, C ;
Marianneau, P ;
Marendat, I ;
Georges-Courbot, MC ;
Deubel, V .
MICROBES AND INFECTION, 2006, 8 (05) :1194-1202
[4]   Marburg hemorrhagic fever associated with multiple genetic lineages of virus [J].
Bausch, Daniel G. ;
Nichol, Stuart T. ;
Muyembe-Tamfum, Jean Jacques ;
Borchert, Matthias ;
Rollin, Pierre E. ;
Sleurs, Hilde ;
Campbell, Patricia ;
Tshioko, Florimund K. ;
Roth, Catherine ;
Colebunders, Robert ;
Pirard, Patricia ;
Mardel, Simon ;
Olinda, Loku A. ;
Zeller, Herve ;
Tshomba, Antoine ;
Kulidri, Amayo ;
Libande, Modeste L. ;
Mulangu, Sabue ;
Formenty, Pierre ;
Grein, Thomas ;
Leirs, Herwig ;
Braack, Leo ;
Ksiazek, Tom ;
Zaki, Sherif ;
Bowen, Michael D. ;
Smit, Sheilagh B. ;
Leman, Patricia A. ;
Burt, Felicity J. ;
Kemp, Alan ;
Swanepoel, Robert .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :909-919
[5]   Lassa Fever in Guinea: I. Epidemiology of Human Disease and Clinical Observations [J].
Bausch, Daniel G. ;
Demby, Austin H. ;
Coulibaly, Mamadi ;
Kanu, James ;
Goba, Augustine ;
Bah, Alpha ;
Conde, Nancouma ;
Wurtzel, Heather L. ;
Cavallaro, Kathleen F. ;
Lloyd, Ethleen ;
Baldet, Fatoumata Binta ;
Cisse, Sekou D. ;
Fofona, Djicondet ;
Savane, Ibrahim K. ;
Tolno, Robert Tamba ;
Mahy, Barry ;
Wagoner, Kent D. ;
Ksiazek, Thomas G. ;
Peters, C. J. ;
Rollin, Pierre E. .
VECTOR-BORNE AND ZOONOTIC DISEASES, 2001, 1 (04) :269-+
[6]   Aniru Conteh 1942-2004 - In memoriam [J].
Bausch, DG ;
Sesay, SSS ;
Oshin, B .
EMERGING INFECTIOUS DISEASES, 2004, 10 (10) :1889-1890
[7]   Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation [J].
Bausch, DG ;
Rollin, PE ;
Demby, AH ;
Coulibaly, M ;
Kanu, J ;
Conteh, AS ;
Wagoner, KD ;
McMullan, LK ;
Bowen, MD ;
Peters, CJ ;
Ksiazek, TG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2670-2677
[8]  
BAUSCH DG, 2007, EBOLA MARBURG VIRUSE
[9]   Envelope exchange for the generation of live-attenuated arenavirus vaccines [J].
Bergthaler, Andreas ;
Gerber, Nicolas U. ;
Merkler, Doron ;
Horvath, Edit ;
Carlos de la Torre, Juan ;
Pinschewer, Daniel D. .
PLOS PATHOGENS, 2006, 2 (06) :501-512
[10]   Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis [J].
Bernard, GR ;
Macias, WL ;
Joyce, DE ;
Williams, MD ;
Bailey, J ;
Vincent, JL .
CRITICAL CARE, 2003, 7 (02) :155-163